Oxazole Compounds Activate IDO1 and AhR to Modulate Immune Response

Solution Overview

Problem

Current methods lack effective agents to modulate immune responses in patients with cancer, autoimmune diseases, or post-surgical infections by targeting indoleamine 2,3-dioxygenase 1 (IDO1) and aryl hydrocarbon receptor (AhR), which are crucial for immune tolerance and inflammation regulation.

Innovation Solution

Administering agents that increase the level or activity of IDO1 or AhR, such as small molecules, antibodies, peptides, or nucleic acids, to stimulate the immune system, including specific compounds like those represented by Formulas (I), (II), (III), and (IV), which can be formulated with pharmaceutically acceptable carriers and adjuvants, to enhance immune responses in subjects with cancer, immune deficiencies, or infections.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If agents that increase IDO1 or AhR activity are administered, then immune response stimulation is improved, but anti-inflammatory cytokine secretion reduction may cause excessive inflammation

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent employs parameter changes by modifying the chemical structure of oxazole compounds (Formulas I-IV) to optimize their ability to activate IDO1 and AhR pathways. By adjusting molecular parameters such as substituents R1-R6, ring structures, and functional groups, the compounds achieve enhanced immune stimulation while controlling inflammatory responses through precise biochemical parameter modulation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The oxazole compounds act as intermediaries that bridge the gap between immune stimulation and inflammation control. These compounds selectively activate IDO1 and AhR pathways while modulating cytokine production, serving as mediators that translate chemical structure into controlled immunological effects without causing excessive inflammation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If multiple types of agents (small molecules, antibodies, peptides, nucleic acids) are used to target IDO1 and AhR, then immune modulation effectiveness is improved, but device complexity increases

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies universality by developing a single class of oxazole compounds that can function through multiple mechanisms - directly activating IDO1, modulating AhR pathways, and influencing cytokine production. This multi-functional approach consolidates what would otherwise require multiple different agents into one versatile compound class, reducing overall system complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent utilizes composite material principles by formulating oxazole compounds with specific structural combinations (heterocyclic rings, substituents, functional groups) that integrate multiple pharmacological activities into a single molecular entity. This composite molecular structure achieves the effectiveness of multiple agents while simplifying the formulation into a unified therapeutic compound

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The proposed method stimulates immune responses by reducing anti-inflammatory cytokines and increasing immune cell activity, effectively addressing immune-related disorders and enhancing vaccination efficacy.

Implementation Method 1

Indoleamine 2,3,dioxygenase 1 (IDO1), is a cell marker highly expressed in the colon of patients suffering from inflammatory bowel disease (IBD) as well as in many animal models of colitis. In the hematopoietic system, elevated IDO1 expression and subsequent aryl hydrocarbon receptor (AhR) activation have been associated with immune tolerance

Methodology Applied
Scientific EffectEnzymatic oxidation: Oxidation

Data Source

PatentUS11591300B2Oxazole containing compounds as activators of IDO1 and AhR
Publication Date: 2023.02.28
  • US11591300B2 patent drawing
  • US11591300B2 patent drawing
  • US11591300B2 patent drawing

AI summary

Provided herein are methods and compositions related to a method of stimulating the immune system in a subject in need thereof by administering an agent that increases the level or activity of indoleamine 2,3-dioxygenase (IDO1) and/or aryl hydrocarbon receptor (Ahr).